sulfasalazine has been researched along with Infections, Helicobacter in 7 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "pylori." | 2.69 | Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease. ( Duncan, HD; Green, JR; Pearce, CB; Timmis, L, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wada, T | 1 |
| Ishimoto, T | 1 |
| Seishima, R | 1 |
| Tsuchihashi, K | 1 |
| Yoshikawa, M | 1 |
| Oshima, H | 1 |
| Oshima, M | 1 |
| Masuko, T | 1 |
| Wright, NA | 1 |
| Furuhashi, S | 1 |
| Hirashima, K | 1 |
| Baba, H | 1 |
| Kitagawa, Y | 1 |
| Saya, H | 1 |
| Nagano, O | 1 |
| Mantzaris, GJ | 1 |
| Archavlis, E | 1 |
| Zografos, C | 1 |
| Zavos, K | 1 |
| Petraki, K | 1 |
| Triadaphyllou, G | 1 |
| Sternon, J | 1 |
| Adler, M | 1 |
| Parente, F | 1 |
| Molteni, P | 1 |
| Bollani, S | 1 |
| Maconi, G | 1 |
| Vago, L | 1 |
| Duca, PG | 1 |
| Rembacken, B | 1 |
| Axon, AT | 1 |
| Bianchi Porro, G | 1 |
| Pearce, CB | 1 |
| Duncan, HD | 1 |
| Timmis, L | 1 |
| Green, JR | 1 |
| Münzová, H | 1 |
| Dítĕ, P | 1 |
| Sevcíková, I | 1 |
| Dolina, J | 1 |
| Novotný, I | 1 |
| Kunovská, M | 1 |
| Taha, AS | 1 |
| Sturrock, RD | 1 |
| Russell, RI | 1 |
1 review available for sulfasalazine and Infections, Helicobacter
| Article | Year |
|---|---|
[Digestive and extra-digestive complications of nonsteroidal anti-inflammatory drugs. Preventive and curative strategies].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cyclooxygenase | 1997 |
1 trial available for sulfasalazine and Infections, Helicobacter
| Article | Year |
|---|---|
Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Breath Tests; Colitis, Ulcera | 2000 |
5 other studies available for sulfasalazine and Infections, Helicobacter
| Article | Year |
|---|---|
Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia.
Topics: Adenocarcinoma; Amino Acid Transport System y+; Animals; Biomarkers, Tumor; Cell Transformation, Neo | 2013 |
Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulfasalazine.
Topics: Adult; Aged; Anti-Inflammatory Agents; Colitis, Ulcerative; Helicobacter Infections; Helicobacter py | 1995 |
Prevalence of Helicobacter pylori infection and related upper gastrointestinal lesions in patients with inflammatory bowel diseases. A cross-sectional study with matching.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Colitis, Ulcerative; Crohn Disease; Cross-Sectional | 1997 |
[Helicobacter pylori and nonspecific intestinal inflammation].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Bacterial; Colitis, Ul | 2000 |
Helicobacter pylori and peptic ulcers in rheumatoid arthritis patients receiving gold, sulfasalazine, and nonsteroidal anti-inflammatory drugs.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Duodenal Ulcer; Female; Gold S | 1992 |